Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-05-13 | Lu AA21004 | major depressive disorder (MDD) | 3 | Lundbeck (Denmark) Takeda Pharmaceutical Company (Japan) | Mental diseases - CNS diseases |
2011-05-12 | AB103 | 1 | Atox Bio (Israel) | Infectious diseases | |
2011-05-11 | SPC4955 | high cholesterol | 1 | Santaris Pharma (Denmark) | Cardiovascular diseases |
2011-05-11 | combination regimen of IL-7 (CYT107) and Xeloda® (capecitabine) | metastatic breast cancer | 2a | Cytheris (France) Centre Léon Bérard (France) ImmunID (France) | Cancer - Oncology |
2011-05-09 | AP214 | protection of kidney injury in patients undergoing cardiac surgery under cardiopulmonary bypass |
2b | Action Pharma (Denmark) | Renal diseases - Cardiovascular diseases - Kidney diseases |
2011-05-05 | Catena® (idebenone) | Friedreich's ataxia |
2 | Santhera Pharmaceutical (Switzerland) | Neurodegenerative diseases |
2011-05-04 | SPC5001 | high cholesterol | 1 | Santaris Pharma (Denmark) | Metabolic diseases - Cardiovascular diseases |
2011-05-04 | Vaccine Enhancement Patch in combination with GSK's H5N1 pandemic Influenza antigen | pandemic influenza | 1 | Intercell (Austria) GSK (UK) | Infectious diseases |
2011-04-29 | SEN0014196 (6-chloro-2,33,4,9-tetrahyddro-1H-carbaazole-1-carbooxamide) | Huntington's Disease |
2 | Siena Biotech (Italy) | Genetic diseases - Neurodegenerative diseases - Rare diseases |
2011-04-28 | Vyvanse® (lisdexamfetamine dimesylate) | negative symptom predominant schizophrenia |
Shire (UK-USA) | Mental diseases - CNS diseases | |
2011-04-28 | MGN1703 (lefitolimod) | colorectal cancer | 2-3 | Mologen (Germany) | Cancer - Oncology |
2011-04-26 | Zaltrap® (aflibercept) | second-line treatment of metastatic colorectal cancer |
3 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cancer Oncology |
2011-04-26 | KUR-113 | open tibial shaft fracture | 2b | Kuros Biosurgery (Switzerland) | |
2011-04-26 | belinostat | refractory or relapsed Hodgkin’s or Non-Hodgkin’s lymphoma | 1 | Topotarget (Denmark) | Cancer - Oncology |
2011-04-20 | ATH008 | hand-foot syndrome (or palmar-plantar erythrodysesthesia syndrome) |
2b | Advancell (Spain) | Dermatological diseases - Cancer - Oncology |
2011-04-19 | influenza vaccine produced in EB66® cells | influenza | The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) (Japan) | Infectious diseases | |
2011-04-18 | novel therapeutic vaccination strategy against genotype 1 hepatitis C virus (HCV) | hepatitis C | 1 | Inovio Pharmaceuticals (USA) Transgene (France) ChronTech Pharma (Sweden) | Infectious diseases |
2011-04-18 | BC-3781 | acute bacterial skin and skin structure infections (ABSSSI) | 2 | Nabriva Therapeutics (Austria) | Infectious diseases |
2011-04-15 | GLPG0259 | rheumatoid arthritis | 2 | Galapagos (Belgium) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
2011-04-14 | Catioprost® | glaucoma | 2 | Novagali Pharma (France) | Ophtalmological diseases |